Treatment Of Recurrent, Platinum-Resistant Ovarian Cancer With Glutaminase 1 And PARP Inhibitors

Grant

Date/time Interval

  • April 1, 2018 - March 31, 2021
  • Total Award Amount

  • 1020518.00
  • Direct Costs

  • 783457.00
  • Sponsor Award Id

  • W81XWH-17-1-0225
  • Contributor

  • Birrer M.D., Ph.D. M.D., Ph.D., Michael J.   Principal Investigator